Agilon Health's (AGL) "Sell (E+)" Rating Reaffirmed at Weiss Ratings

Key Points

• Agilon Health's stock has been reaffirmed with a "sell (e+)" rating by Weiss Ratings, indicating ongoing concerns about its performance.
• Recent revisions by research analysts have significantly lowered target prices for Agilon Health, with estimates ranging from $1.00 to $3.00 compared to previous highs of $5.00.
• The company reported a loss of ($0.25) earnings per share in its latest quarter, missing expectations and showing a 5.9% year-over-year revenue decline.

Agilon Health (NYSE:AGL - Get Free Report)'s stock had its "sell (e+)" rating reissued by investment analysts at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Several other research analysts have also recently issued reports on the stock. Sanford C. Bernstein reiterated a "market perform" rating and issued a $1.40 price objective (down from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Evercore ISI reduced their target price on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a report on Wednesday, July 9th. Robert W. Baird reduced their target price on shares of Agilon Health from $5.00 to $1.00 and set a "neutral" rating for the company in a report on Thursday, August 14th. Benchmark reduced their target price on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a report on Wednesday, August 6th. Finally, Wells Fargo & Company reduced their target price on shares of Agilon Health from $5.00 to $1.50 and set an "overweight" rating for the company in a report on Tuesday. Four investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $2.81.

Agilon Health Price Performance

Shares of Agilon Health stock traded down $0.02 on Wednesday, hitting $1.05. The company had a trading volume of 4,950,945 shares, compared to its average volume of 7,072,596. The business has a 50-day simple moving average of $1.18 and a 200-day simple moving average of $2.43. The company has a market cap of $433.07 million, a PE ratio of -1.36 and a beta of 0.07. Agilon Health has a 52 week low of $0.71 and a 52 week high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.14). The company had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The company's revenue was down 5.9% on a year-over-year basis. During the same quarter last year, the business earned ($0.07) earnings per share. On average, equities research analysts predict that Agilon Health will post -0.59 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AGL. Wealth Enhancement Advisory Services LLC purchased a new stake in Agilon Health in the 4th quarter worth approximately $155,000. Rhumbline Advisers raised its holdings in shares of Agilon Health by 4.8% during the 1st quarter. Rhumbline Advisers now owns 439,781 shares of the company's stock valued at $1,904,000 after purchasing an additional 20,194 shares in the last quarter. Pallas Capital Advisors LLC bought a new position in shares of Agilon Health during the 1st quarter valued at $66,000. Simplicity Wealth LLC bought a new position in shares of Agilon Health during the 1st quarter valued at $186,000. Finally, SG Americas Securities LLC raised its holdings in shares of Agilon Health by 1,271.3% during the 1st quarter. SG Americas Securities LLC now owns 144,189 shares of the company's stock valued at $624,000 after purchasing an additional 133,674 shares in the last quarter.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.